MTOR and breast cancer: Its anticancer effect has been observed in a wide range of cancers, including breast cancer [25], lung cancer [26], and pancreatic cancer [27], involving a number of signaling pathways, such as MAPK, PI3K/AKT/mTOR, NF-κB, and Wnt/β-Catenin [28].